These results suggested that the LV expressing a therapeutic gene driven by the CD68 promoter may be a powerful tool as a therapeutic strategy for ALS by cell-based gene delivery to the spinal cord using BMDCs. This evidence concerns the gene CD68 and amyotrophic lateral sclerosis.